Baker Bros. Advisors LP Infinity Pharmaceuticals, Inc. Transaction History

Baker Bros. Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.98 - $5.36 $1.03 Million - $2.8 Million	-522,360 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.05 - $2.77 $60,942 - $160,770	-58,040 Reduced 10.0%	522,360 $1.11 Million
Q3 2017 Nov 14, 2017	BUY	$0.94 - $1.35 $545,576 - $783,540	580,400	580,400 $772,000

1.27M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.